Moreover, M. Szrejder’s study revealed that the effect of metformin on nephrin protein levels in podocytes is AMPK-dependent because of the fact that AMPK inhibitor, compound C, decreased nephrin protein levels in normoglycemic (control) podocytes to values observed in podocytes cultivated in hyperglycemia [128]. This evidence concerns the gene NPHS1 and Hyperglycemia.